Seventure Partners is a leading force in European venture capital and growth equity. Since 1997, the management company, based in key regions in Europe, has been the preferred partner for entrepreneurs who ambition to redefine the boundaries Life Sciences and Digital Technologies, generating positive impacts on People, Society, Sustainability and the Planet.
In the field of Life Sciences, Seventure invests mainly in “classic” approaches, such as drugs, medical devices and diagnostics, and industrial biotechnology, as well as “beyond the pill” approaches, such as digital health, preventive medicine, wellbeing, personalized medicine, nutrition and food, with a particular interest in the applications of discoveries related to the microbiome and foodtech.
The fl agship Health for Life Capital™ funds have attracted strategic investments from prestigious organizations including Danone, Novartis, two US-based global food ingredient providers (to be disclosed), Lesaffre, Tornier, Tereos, Unigrains and Bel, as well as financial institutions, family offices and entrepreneurs.

contact person

Annegret de Baey-Diepolder MD Venture Partner Life Sciences Department	Isabelle de Cremoux CEO and Managing Partner

Capital under management
~€1b net commitments under management as of the end of 2025
• The Healthcare & Planetary Health funds Health for Life Capital™ funds I, II, III
• The Sport funds (Sport & Performance Capital ) the leading investment vehicles for sportech innovation in Europe and the US.
• The Blue Economy funds (ocean and water ) (BlueFowardFund) are set to disrupt the sustainable innovation in marine sector, in industrial biotech or animal feeding.

Investment requirements and financing offer
Seventure’s investments can range between €500k and €10m per round, or up to €20m per company, to support the development of companies from creation (seed and first round) to development capital financing rounds (venture, growth, pre-IPO and IPO).

Industry focus
• Life Sciences: englobes biotechnology, medtech & digital health, nutrition, foodtech, blue economy, aquaculture, animal feed, agriculture, sportech & wellness, with a particular focus on the microbiome, across Europe, Israel, Asia, Australia and North America,
• Digital Technologies: include, but is not limited to: fintech, retailtech, cybersecurity, across Europe, mainly in France and Germany.

Portfolio and exits
• Seventure has a portfolio of more than 150 companies across all its funds.
• Acquisitions and IPO include: Foodsmart, Cambrooke, Polaris, MaaT, Medincell, Mauna Kea, TargeDys, The Akkermansia Company, Argenx, Larq, Pixium Vision, Mainstay Medical, Ipsogen, Biancamed, Bioalliance Pharma, Advanced Accelerator Applications, Biomatlante, Middle Peak, Biophytis, Santaris Pharma, Implanet, Syntaxin, Nanobiotix, Global Bioenergies, Metabolic Explorer, OPi

Date of foundation/ Number of employees
1997/30

contact information

Address: 5-7 rue de Monttessuy, 75007 Paris, France
Telephone: +33 1 57 95 03 92
E-Mail: contact@seventure.fr
Social Media: www.linkedin.com/company/seventure-partners
Web Address: www.seventure.fr/en